Bo Pei
Hubei Key Laboratory Of Tumor Biological Behaviors
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Combining Cetuximab and Immunotherapy for Treating MSS/pMMR Colorectal Cancer: Current Evidence and Challenges.
Journal: Technology in cancer research & treatment
Published: May 07, 2025
Multi-center phase II study of nab-paclitaxel plus camrelizumab versus nab-paclitaxel alone as second-line treatment for advanced gastric cancer.
Journal: The oncologist
Published: January 07, 2025
Cabozantinib as the first step toward postimmunotherapy treatment in hepatocellular carcinoma.
Journal: Journal of surgical oncology
Published: May 28, 2024
Renewed call for action: Highlight negative results to improve science.
Journal: Clinics (Sao Paulo, Brazil)
Published: May 27, 2024
Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq.
Journal: Technology in cancer research & treatment
Published: May 20, 2024
SOX17 orchestrates immune evasion in early colorectal adenomas and cancers.
Journal: Immunology
Published: April 18, 2024
Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: February 29, 2024
Bifidobacterium modulation of tumor immunotherapy and its mechanism.
Journal: Cancer immunology, immunotherapy : CII
Published: November 29, 2023
The clinicopathological significance and potential function of ULK1 in colon cancer.
Journal: Biotechnology & genetic engineering reviews
Published: May 16, 2023
Effects of selenium supplementation on concurrent chemoradiotherapy in patients with cervical cancer: A randomized, double-blind, placebo-parallel controlled phase II clinical trial.
Journal: Frontiers in nutrition
Published: November 09, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026